| 000 | 01103 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514015054.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a1525-4135 | ||
| 024 | 7 |
_a10.1097/00042560-200111010-00020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlahn, J A | |
| 245 | 0 | 0 |
_aHIV serostatus as a function of drug treatment setting. _h[electronic resource] |
| 260 |
_bJournal of acquired immune deficiency syndromes (1999) _cNov 2001 |
||
| 300 |
_a308 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aDrug Therapy _xmethods |
| 650 | 0 | 4 |
_aHIV _ximmunology |
| 650 | 0 | 4 |
_aHIV Infections _xetiology |
| 650 | 0 | 4 | _aHIV Seropositivity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRisk-Taking |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xcomplications |
| 700 | 1 | _aFisher, D G | |
| 700 | 1 | _aWood, J L | |
| 773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 28 _gno. 3 _gp. 308 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00042560-200111010-00020 _zAvailable from publisher's website |
| 999 |
_c11610441 _d11610441 |
||